ALXO
ALX Oncology·NASDAQ
--
--(--)
--
--(--)
5.55 / 10
Netural
Money-flow analysis shows an exceptional 8.0/10, with small-cap inflows positive and larger blocks negative, hinting at retail-driven momentum. Analyst coverage is thin but unanimous at Strong Buy, adding sentiment support despite limited historical win rates.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-05-21
InstitutionUBS
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of ALXO?
- ALXO holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.55/10 (Netural).
